Mike Mensinger insider trades

Open-market stock purchases and sales by Mike Mensinger, Chief Product Officer at Beta Bionics, Inc, from SEC Form 4 filings since Jan 29, 2025.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +27%.

Recent trades

DateStockTradeValue
Sep 16, 2026BBNX Beta Bionics, IncSold$58.3K
Sep 2, 2026BBNX Beta Bionics, IncSold$83.6K
Jun 2, 2026BBNX Beta Bionics, IncSold$55.2K
Mar 2, 2026BBNX Beta Bionics, IncSold$13.2K
Feb 27, 2026BBNX Beta Bionics, IncBought (not open market)—
Feb 27, 2026BBNX Beta Bionics, IncBought (not open market)—
Feb 27, 2026BBNX Beta Bionics, IncBought (not open market)—
Jan 6, 2026BBNX Beta Bionics, IncSold$66.2K
Jan 2, 2026BBNX Beta Bionics, IncSold$213K
Jan 2, 2026BBNX Beta Bionics, IncSold$18.1K
Dec 2, 2025BBNX Beta Bionics, IncSold$31.2K

Companies traded

  • BBNX Beta Bionics, Inc: 1 buy, 13 sales, last Sep 16, 2026

Get free alerts when Mike Mensinger files a new trade →